NASDAQ
InMed Pharmaceuticals Inc. (INM) has a eps (basic) of $-8.36 as of Monday, June 30, 2025. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.
No price data available for this timeframe.